Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002) Ended

2025-524852-74-00 Hypercholesterolaemia 3 2026-03-11
A clinical trial to learn more about the effects of DII235 in people with high levels of lipoprotein(a) Ended

2025-521912-21-00 Cardiovascular risk reduction in participants with elev 4 2026-01-26
A clinical study of enlicitide in people with high cholesterol (MK-0616-037) Ended

2025-521495-54-00 Hyperlipidemia 5 2025-12-20
A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Ended

2025-521970-33-00 Pulmonary Arterial Hypertension (PAH) 5 2025-12-19
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended

2025-520520-17-00 Heterozygous familial hypercholesterolaemia 5 2025-09-05
A Study to Find Out How Safe and Well AZD0780 Works for Adults with High 'Bad' Cholesterol and with Heart- Stroke or Vascular Disease or at … Ended

2025-520521-21-00 Hyperlipidemia 5 2025-09-02
A Phase 2 Multicenter Study to Test the Effects of ALXN2220 on Markers of Disease Severity and the Safety of Re-Treatment in Patients with T… Ended

2025-520506-35-00 Adults with Transthyretin Amyloid Cardiomyopathy (ATTR- 4 2025-06-30
A clinical study of sotatercept in people with pulmonary arterial hypertension Ended

2024-518687-12-00 Pulmonary Arterial Hypertension (PAH) 4 2025-06-19
A clinical study of sotatercept in people with pulmonary hypertension (MK-7962-023) Ended

2024-515773-99-00 Pulmonary Hypertension 4 2025-05-26
A Study to Learn How the Study Medicine Called PF-07868489 is Tolerated and Acts in Healthy Adult People and People With Pulmonary Arterial … Ended

2024-514064-17-00 Pulmonary Arterial Hypertension 3 2025-05-23
Semaglutide for people with obesity and resistant hypertension (SUPPORT): a pilot, randomized, parallel-group, integrated, multicentre clini… Ended

2024-513958-29-00 Cardiovascular disorders: Hypertension and Obesity 5 2025-04-24
The Pragmatic EE-PRS Trial assessing Polygenic Risk Driven Statin Therapy for Cardiovascular Disease Prevention Ended

2024-513424-42-01 High polygenic risk for coronary artery disease 6 2025-03-25
Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults. Ended

2024-515286-34-00 Healthy Volunteer 1 2025-03-06
A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Ended

2024-518343-38-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-02-12
"Comparison between norepinephrine and dobutamine in patients with cardiogenic shock" Ended

2024-520399-84-00 Cardiogenic shock 6 2025-02-03
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 acute coronary syndrome 6 2025-01-29
A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension… Ended

2024-513991-16-00 Pulmonary Hypertension Associated with Interstitial Lun 4 2025-01-17
A 24-Week Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF) (… Ended

2024-514283-40-00 Pulmonary Hypertension 4 2024-12-19
Potential protective role of SGLT-2 inhibitors for chemotherapy-induced cardiotoxicity (PROTECT trial) Ended

2024-518611-18-00 Chemotherapy-induced cardiotoxicity in breast cancer 4 2024-12-03
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction Ended

2024-511882-13-01 Cardiac failure 5 2024-11-19
Prevention of cardiac Dysfunction during Adjuvant breast cancer therapy: A Randomized, Placebo-controlled, Multicenter Trial (PRADA-II) Ended

2024-515323-11-00 Heart Failure 4 2024-11-13
GenePHIT: A study to learn more about how well a new gene therapy (AB-1002) works and its safety in participants with congestive heart failu… Ended

2024-510581-17-00 Adult subjects with New York Heart Association (NYHA) C 4 2024-11-05
Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease - Randomized Delayed… Ended

2024-514543-28-00 patients with stable coronary artery disease 4 2024-10-21
Effects of the combination of two drugs called irbesartan and amlodipine, in one pill in patients with high blood pressure. Ended

2024-511705-31-00 Arterial Hypertension 5 2024-09-26